Evolus, Inc. (EOLS)
NASDAQ
Market Cap
$775.37M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
661 of 966
Rank in Industry
41 of 59
Largest Insider Buys in Sector
EOLS Stock Price History Chart
EOLS Stock Performance
About Evolus, Inc.
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Insider Activity of Evolus, Inc.
Over the last 12 months, insiders at Evolus, Inc. have bought $0 and sold $9.21M worth of Evolus, Inc. stock.
On average, over the past 5 years, insiders at Evolus, Inc. have bought $3.4M and sold $18.4M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 174,967 shares for transaction amount of $1.3M was made by Malik Vikram (director) on 2023‑08‑15.
List of Insider Buy and Sell Transactions, Evolus, Inc.
| 2024-09-06 | Sale | Chief Financial Officer | 3,276 0.0053% | $14.98 | $49,074 | +10.94% | ||
| 2024-08-30 | Sale | Chief Marketing Officer | 5,631 0.0089% | $15.85 | $89,251 | +2.08% | ||
| 2024-06-06 | Sale | See Remarks | 175,940 0.2852% | $12.59 | $2.21M | +16.90% | ||
| 2024-06-05 | Sale | See Remarks | 155,278 0.2465% | $12.92 | $2.01M | +9.75% | ||
| 2024-06-04 | Sale | See Remarks | 140,214 0.2217% | $12.73 | $1.78M | +10.15% | ||
| 2024-06-03 | Sale | director | 7,500 0.0119% | $12.96 | $97,203 | +7.75% | ||
| 2024-05-14 | Sale | director | 6,718 0.0106% | $12.60 | $84,654 | +6.02% | ||
| 2024-05-13 | Sale | director | 28,000 0.0459% | $12.93 | $362,012 | +7.14% | ||
| 2024-05-13 | Sale | director | 3,643 0.0059% | $12.72 | $46,356 | +7.14% | ||
| 2024-05-10 | Sale | See Remarks | 16,051 0.0256% | $12.72 | $204,127 | +5.61% | ||
| 2024-05-10 | Sale | See Remarks | 3,441 0.0055% | $12.72 | $43,761 | +5.61% | ||
| 2024-05-10 | Sale | Chief Financial Officer | 2,423 0.0039% | $12.72 | $30,814 | +5.61% | ||
| 2024-03-27 | Sale | See Remarks | 6,236 0.01% | $13.86 | $86,431 | -5.64% | ||
| 2024-03-19 | Sale | See Remarks | 96,566 0.1564% | $13.92 | $1.34M | -5.15% | ||
| 2024-03-19 | Sale | See Remarks | 27,603 0.0447% | $13.92 | $384,350 | -5.15% | ||
| 2024-03-19 | Sale | Chief Financial Officer | 5,672 0.0092% | $13.92 | $78,978 | -5.15% | ||
| 2024-02-22 | Sale | See Remarks | 7,706 0.0134% | $13.08 | $100,804 | +2.66% | ||
| 2024-02-22 | Sale | See Remarks | 1,821 0.0032% | $13.08 | $23,821 | +2.66% | ||
| 2024-02-22 | Sale | Chief Financial Officer | 1,821 0.0032% | $13.08 | $23,821 | +2.66% | ||
| 2024-01-30 | Sale | director | 11,931 0.0211% | $13.14 | $156,733 | +4.27% |
Insider Historical Profitability
<0.0001%
| MOATAZEDI DAVID | See Remarks | 533349 0.8423% | $12.25 | 0 | 19 | |
| Avelar Rui | See Remarks | 368847 0.5825% | $12.25 | 0 | 9 | |
| Malik Vikram | director | 246514 0.3893% | $12.25 | 4 | 7 | <0.0001% |
| Beaver Sandra | Chief Financial Officer | 148502 0.2345% | $12.25 | 0 | 6 | |
| Yamagishi-Dressler Tomoko | Chief Marketing Officer | 82375 0.1301% | $12.25 | 0 | 1 | |
| GILL DAVID N | director | 33964 0.0536% | $12.25 | 2 | 3 | +8.2% |
| Parschauer Karah Herdman | director | 31243 0.0493% | $12.25 | 0 | 1 | |
| Alphaeon Corp | 10 percent owner | 8662346 13.6799% | $12.25 | 0 | 6 | |
| Alphaeon 1 LLC | 10 percent owner | 4214871 6.6563% | $12.25 | 0 | 2 | |
| Medytox Inc. | 3381326 5.3399% | $12.25 | 15 | 9 | <0.0001% | |
| Jafar Michael M. | See Remarks | 174851 0.2761% | $12.25 | 1 | 1 | <0.0001% |
| SILVERNAIL LAUREN P | See Remarks | 141571 0.2236% | $12.25 | 0 | 5 | |
| Muilenburg Crystal | Chief Marketing Officer | 134248 0.212% | $12.25 | 0 | 2 | |
| BLANK SIMONE | 54881 0.0867% | $12.25 | 3 | 0 | <0.0001% | |
| Hau Bosun | director | 10040 0.0159% | $12.25 | 2 | 0 | <0.0001% |
| FARRELL PETER C | 10000 0.0158% | $12.25 | 1 | 0 | <0.0001% | |
| HAYMAN ROBERT | director | 10000 0.0158% | $12.25 | 3 | 0 | <0.0001% |
| Romine Kristine | director | 3450 0.0054% | $12.25 | 10 | 0 | <0.0001% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Perceptive Advisors | $80.55M | 9.19 | 5.75M | +45.17% | +$25.07M | 0.05 | |
| Tang Capital Management, LLC | $58.06M | 6.62 | 4.15M | +33.9% | +$14.7M | 0.22 | |
| BlackRock | $45.65M | 5.21 | 3.26M | -2.35% | -$1.1M | <0.01 | |
| Morgan Stanley | $42.6M | 4.86 | 3.04M | +17.81% | +$6.44M | <0.01 | |
| Nantahala Capital Management Llc | $40.75M | 4.65 | 2.91M | 0% | +$0 | 1.9 | |
| The Vanguard Group | $40.68M | 4.64 | 2.91M | -1.29% | -$532,028.00 | <0.01 | |
| Stonepine Capital Management Llc | $37.44M | 4.27 | 2.67M | -49.85% | -$37.22M | 2.25 | |
| Great Point Partners | $34.3M | 3.91 | 2.45M | +22.5% | +$6.3M | 5.75 | |
| Caligan Partners LP | $26.44M | 3.02 | 1.89M | +43.33% | +$7.99M | 6.99 | |
| Deutsche Bank | $21.56M | 2.46 | 1.54M | +8.89% | +$1.76M | 0.01 | |
| State Street | $14.46M | 1.65 | 1.03M | +0.6% | +$86,716.00 | <0.01 | |
| D. E. Shaw & Co. | $13.69M | 1.56 | 977,578 | +37.97% | +$3.77M | 0.01 | |
| Boothbay Fund Management LLC | $13.62M | 1.55 | 973,102 | +16.27% | +$1.91M | 0.44 | |
| Geode Capital Management | $13.44M | 1.53 | 959,559 | +2.71% | +$354,012.98 | <0.01 | |
| Millennium Management LLC | $13.11M | 1.5 | 936,373 | -6.7% | -$941,416.00 | 0.01 | |
| Rice Hall James & Associates, LLC | $12.33M | 1.41 | 880,744 | -2.81% | -$356,314.00 | 0.73 | |
| Soros Fund Management | $11.76M | 1.34 | 840,100 | +52.74% | +$4.06M | 0.49 | |
| Schroder Investment Management Group | $11.66M | 1.33 | 832,798 | -28.31% | -$4.61M | 0.01 | |
| Lord Abbett | $11.63M | 1.33 | 830,532 | New | +$11.63M | 0.04 | |
| Nuveen | $9.13M | 1.04 | 652,265 | -29.32% | -$3.79M | <0.01 | |
| AWH Capital LP | $8.83M | 1.01 | 630,500 | +0.2% | +$17,640.00 | 8.13 | |
| UBS | $8M | 0.91 | 571,182 | -14.27% | -$1.33M | <0.01 | |
| Oberweis Asset Management Inc | $5.56M | 0.64 | 397,300 | +6.97% | +$362,600.00 | 0.4 | |
| Northern Trust | $5.37M | 0.61 | 383,621 | -1.79% | -$97,930.00 | <0.01 | |
| Cubist Systematic Strategies | $4.48M | 0.51 | 320,097 | +43.7% | +$1.36M | 0.04 | |
| Zimmer Partners Lp | $4.2M | 0.48 | 300,000 | New | +$4.2M | 0.09 | |
| Susquehanna International Group | $4.18M | 0.48 | 298,358 | +1,972.51% | +$3.98M | <0.01 | |
| Divisadero Street Capital Management Lp | $3.78M | 0.43 | 270,162 | +17.11% | +$552,468.00 | 0.89 | |
| Qube Research & Technologies | $3.75M | 0.43 | 267,945 | +481.33% | +$3.11M | 0.01 | |
| Voloridge Investment Management, LLC | $3.67M | 0.42 | 262,135 | New | +$3.67M | 0.01 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $3.57M | 0.41 | 254,811 | +1.5% | +$52,654.00 | 0.72 | |
| JPMorgan Chase | $3.47M | 0.4 | 247,656 | +543.71% | +$2.93M | <0.0001 | |
| Trexquant Investment LP | $3.42M | 0.39 | 244,029 | +54.38% | +$1.2M | 0.06 | |
| Marshall Wace | $3.06M | 0.35 | 218,300 | -60.56% | -$4.69M | <0.01 | |
| Walleye Capital | $2.98M | 0.34 | 212,889 | -9% | -$294,868.00 | 0.01 | |
| Point72 Asset Management | $2.75M | 0.31 | 196,200 | New | +$2.75M | <0.01 | |
| Goldman Sachs | $2.61M | 0.3 | 186,275 | +34.68% | +$671,468.00 | <0.0001 | |
| Soleus Capital Management, L.P. | $2.24M | 0.26 | 160,000 | New | +$2.24M | 0.01 | |
| FourWorld Capital Management | $2.15M | 0.25 | 153,620 | -24.56% | -$700,000.00 | 3.08 | |
| Cm Management Llc | $2.1M | 0.24 | 150,000 | 0% | +$0 | 0.04 | |
| Monashee Investment Management LLC | $2.1M | 0.24 | 150,000 | New | +$2.1M | 0.18 | |
| BNY Mellon | $2.03M | 0.23 | 145,333 | -10.33% | -$234,500.00 | <0.0001 | |
| Stifel | $2.03M | 0.23 | 144,906 | -2.25% | -$46,760.00 | <0.01 | |
| Los Angeles Capital Management LLC | $1.91M | 0.22 | 136,226 | New | +$1.91M | 0.01 | |
| Two Sigma | $1.86M | 0.21 | 132,751 | +4.98% | +$88,158.00 | <0.01 | |
| Wellington Management Company | $1.75M | 0.2 | 125,192 | +92.53% | +$842,352.00 | <0.0001 | |
| Russell Investments Group Ltd | $1.56M | 0.18 | 111,769 | 0% | +$0 | <0.01 | |
| Charles Schwab | $1.55M | 0.18 | 110,686 | -3.57% | -$57,302.00 | <0.0001 | |
| Legato Capital Management Llc | $1.51M | 0.17 | 108,210 | 0% | +$0 | 0.18 | |
| Invesco | $1.38M | 0.16 | 98,625 | +586.66% | +$1.18M | <0.0001 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.